Does anyone have an opinion on or experience with Mayne's track record on reliability of their forward looking statements? If they say generic sales will improve, should we take it at face value and rely on it?
- Forums
- ASX - By Stock
- MYX
- News: MYX Mayne Pharma Expects Q4 To Be Stronger Driven By Rebound In Generic Products
MYX
mayne pharma group limited
Add to My Watchlist
1.57%
!
$5.00

News: MYX Mayne Pharma Expects Q4 To Be Stronger Driven By Rebound In Generic Products, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.00 |
Change
-0.080(1.57%) |
Mkt cap ! $406.2M |
Open | High | Low | Value | Volume |
$5.08 | $5.10 | $4.95 | $1.426M | 285.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50 | $5.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.02 | 259 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 7653 | 4.960 |
2 | 971 | 4.940 |
1 | 753 | 4.930 |
1 | 753 | 4.910 |
2 | 12000 | 4.900 |
Price($) | Vol. | No. |
---|---|---|
5.020 | 259 | 1 |
5.060 | 256 | 1 |
5.070 | 753 | 1 |
5.090 | 251 | 1 |
5.100 | 7653 | 5 |
Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |